Petrus Trust Company’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-523
Closed -$220K – 610
2025
Q1
$220K Sell
523
-147
-22% -$63.8K 0.02% 516
2024
Q4
$277K Buy
+670
New +$294K 0.03% 454
2024
Q3
– Sell
-1,378
Closed -$671K – 640
2024
Q2
$671K Buy
+1,378
New +$692K 0.06% 118
2024
Q1
– Sell
-664
Closed -$369K – 712
2023
Q4
$369K Buy
+664
New +$312K 0.03% 357
2020
Q4
– Sell
-515
Closed -$202K – 152
2020
Q3
$202K Buy
+515
New +$190K 0.02% 200
2020
Q1
– Sell
-1,163
Closed -$304K – 250
2019
Q4
$304K Buy
+1,163
New +$306K 0.05% 127
2019
Q2
– Sell
-1,254
Closed -$280K – 314
2019
Q1
$280K Buy
+1,254
New +$259K 0.05% 129
2018
Q4
– Sell
-964
Closed -$241K – 261
2018
Q3
$241K Buy
+964
New +$234K 0.05% 153

Other funds holding IDXX

Petrus Trust Company's IDXX Position: Q2 2025 in Review

Petrus Trust Company sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 523 shares — an estimated $220K sold.

Petrus Trust Company first reported a position in IDXX in Q3 2018 and held it in 8 quarters. The position peaked at $671K in Q2 2024. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Petrus Trust Company reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
  • Petrus Trust Company sold 523 Idexx Laboratories shares in Q2 2025, an estimated $220K.
  • Petrus Trust Company first reported a position in Idexx Laboratories in Q3 2018 and held it in 8 quarters.
  • Petrus Trust Company's Idexx Laboratories position peaked at $671K in Q2 2024.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Petrus Trust Company's 13F filing for Q2 2025, filed 14 Aug 2025.